Based on our group’s rich experience and deep knowledge in this field we have developed a disciplined proven process to ease your way through entire In-Licensing transaction, from initial targeting to deal structuring to post-deal assistance.
At Microsource, we are licensing experts. We work with companies to successfully out-license technologies, compounds, and products at all phases of development.
We assess critical information from the Pharmaceutical market on pipelines, deals, financials, forecasts, and company profiles which cover all you need to base your critical business decisions on.
At Microsource International Group of Companies, we -as the experts in the field- will help you choose the strategy that suits your business best. According to the World Health Organization, the global pharmaceuticals market in 2013 is estimated at $300 billion annually. The figure will rise to $400 by 2016. Six of the 10 largest drugs companies are in the United States. To maintain high sales volumes and stay profitable, companies in the industry can employ a number of business-development strategies.